Neuland Laboratories share news and announcements
NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap
Last close ₹18,865.00down ₹70.00 (0.37%)BSE ₹18,924.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹18,935.00.
52-week range of traded prices to 23 Oct 2026
₹11,500.00Low, 23 Mar 2026₹24,225.00High, 9 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹24,204 Cr356th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 5 Aug 2026
- 48.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 12.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 5 Aug 2026
- 29.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 32.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 53,34748.3% delivered
Neuland Laboratories board meetings
108 filed, newest first. Page 2 of 3.
May 2018
Apr 2018
9 Apr · Board meeting
Jan 2018
Nov 2017
22 Nov · Board meeting
22 Nov · Board meeting
Sep 2017
11 Sep · Board meeting
Aug 2017
May 2017
12 May · Board meeting
Apr 2017
Jan 2017
Nov 2016
Oct 2016
Aug 2016
Jul 2016
May 2016
Apr 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Apr 2015
Jan 2015
9 Jan · Board meeting
Inter-alia to consider and take on record the un-audited financial results of the Company for the quarter ended December 31, 2014.
Oct 2014
29 Oct · Board meeting
Board of Directors of the Company, had at its meeting held on October 29, 2014: Allotted 12,22,472 fully paid up Equity Shares of Face Value of Rs. 10/- each, out of the Rights Issue of 12,25,276 Equity shares and the balance has been kept in abeyance.16 Oct · Board meeting
Inter-alia to consider and take on record the un-audited financial results of the Company for the quarter ended September 30, 2014. Further as per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from October 14, 2014 to October 30, 2014 (both days inclusive), inter alia, for the purpose of announcement of the un-audited Financial Results by the Company.
Aug 2014
Jul 2014
9 Jul · Board meeting
Inter-alia to consider and take on record the un-audited financial results of the Company for the quarter ended June 30, 2014. Further, the Company has informed the Exchange that as per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from July 17, 2014 to August 5, 2014 (both days inclusive), inter alia, for the purpose of announcement of the un-audited Financial Results by the Company.
May 2014
14 May · Board meeting
Board of Directors of the Company at its meeting held on May 09, 2014, had appointed Mrs. Bharati Rao as an Additional Director on the Board of the Company effective May 09, 2014
Apr 2014
Feb 2014
5 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 05, 2014, inter alia, approved the following :(a) Issue of equity shares on Rights basis to the members of the Company not exceeding Rs.25 crores. (b) Constitution of a sub-committee called the Rights Issue Committee to finalize the Rights ratio, issue price, record date and all other matters relating the proposed Rights Issue.
Jan 2014
24 Jan · Board meeting
Inter alia, to consider and take on record the unaudited financial results of the Company for the quarter ended December 31, 2013. Further, as per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from January 21, 2014 to February 06, 2014 (both days inclusive), inter alia, for the purpose of announcement of the Unaudited Financial Results by the Company.
Oct 2013
29 Oct · Board meeting
Inter-alia to consider and take on record the unaudited financial results of the Company for the quarter ended September 30, 2013.
Jul 2013
22 Jul · Board meeting
Inter-alia, to consider and take on record the unaudited financial results of the Company for the quarter ended June 30, 2013.
May 2013
2 May · Board meeting
Inter-alia to consider and take on record the audited financial results of the Company for the year ended March 31, 2013 and to consider and recommend dividend, if any.
Feb 2013
Oct 2012
29 Oct · Board meeting
Inter-alia to consider the unaudited financial results of the Company for the quarter ended September 30, 2012.
Aug 2012
1 Aug · Board meeting
Inter alia consider the unaudited financial results of the Company for the first quarter ended June 30, 2012.
Apr 2012
23 Apr · Board meeting
Inter-alia to consider the audited financial results of the Company for the year ended March 31, 2012.
Feb 2012
16 Feb · Board meeting
Inter alia, (1) To approve the Record Date for the purpose of deciding the shareholders who are eligible to apply for Equity Shares on rights basis in the proposed Issue, (2) To approve the size of the Issue, Issue price, ratio of Rights Entitlement, and other matters pertaining to the issue; (3) To approve the restated financial statement of the Company; (4) To ratify the appointment of bankers to the Issue; (5) To approve the Letter of Offer.
Jan 2012
30 Jan · Board meeting
To inter-alia consider the Unaudited Financial Results of the Company for the quarter ended December 31, 2011.
Oct 2011
18 Oct · Board meeting
To inter-alia consider the unaudited financial results of the company for the quarter ended September 30, 2011.
Jul 2011
20 Jul · Board meeting
To inter alia consider the unaudited financial results of the Company for the quarter ended June 30, 2011.1 Jul · Board meeting
Inter-alia to consider the issue of equity shares on right issue basis to the members of the Company.
May 2011
20 May · Board meeting
Board of Directors of the Company at its meeting held on May 20, 2011 have not recommended any dividend for the financial year ended March 31, 2011.11 May · Board meeting
To inter-alia consider the audited financial results of the company for the year ended March 31, 2011 and consider recommendation of dividend, if any.
Jan 2011
19 Jan · Board meeting
To consider and take on record the Un-audited financial results of the Company for the quarter ended December 31, 2010.
Oct 2010
11 Oct · Board meeting
To consider and take on record the un-audited financial results of the Company for the quarter ended September 30, 2010.